These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2184158)

  • 1. Antimycotic effects of octenidine and pirtenidine.
    Ghannoum MA; Elteen KA; Ellabib M; Whittaker PA
    J Antimicrob Chemother; 1990 Feb; 25(2):237-45. PubMed ID: 2184158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subinhibitory concentration of octenidine and pirtenidine: influence on the lipid and sterol contents of Candida albicans.
    Ghannoum MA; Moussa NM; Whittaker P; Swairjo I; Abu-Elteen KH
    Chemotherapy; 1992; 38(1):46-56. PubMed ID: 1618003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of octenidine and pirtenidine on adhesion of Candida species to human buccal epithelial cells in vitro.
    Ghannoum MA; Abu Elteen K; Stretton RJ; Whittaker PA
    Arch Oral Biol; 1990; 35(4):249-53. PubMed ID: 2378578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the pyridinamines octenidine and pirtenidine on yeast mitochondrial function.
    Ellabib M; Ghannoum MA; Whittaker PA
    Biochem Soc Trans; 1990 Apr; 18(2):342-3. PubMed ID: 2199275
    [No Abstract]   [Full Text] [Related]  

  • 5. Valinomycin affects the morphology of Candida albicans.
    Watanabe H; Azuma M; Igarashi K; Ooshima H
    J Antibiot (Tokyo); 2005 Dec; 58(12):753-8. PubMed ID: 16506692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsicum annuum L. trypsin inhibitor as a template scaffold for new drug development against pathogenic yeast.
    Ribeiro SF; Silva MS; Da Cunha M; Carvalho AO; Dias GB; Rabelo G; Mello EO; Santa-Catarina C; Rodrigues R; Gomes VM
    Antonie Van Leeuwenhoek; 2012 Mar; 101(3):657-70. PubMed ID: 22160750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro susceptibility of Candida albicans and Candida stellatoidea to sulfamethoxazole.
    Kamaya T
    Mycopathol Mycol Appl; 1973 Mar; 49(2):193-200. PubMed ID: 4571243
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae.
    Hiom SJ; Furr JR; Russell AD; Dickinson JR
    J Appl Bacteriol; 1992 Apr; 72(4):335-40. PubMed ID: 1517175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the lipopeptide antibiotic, iturin A, on morphology and membrane ultrastructure of yeast cells.
    Thimon L; Peypoux F; Wallach J; Michel G
    FEMS Microbiol Lett; 1995 May; 128(2):101-6. PubMed ID: 7750727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans and Yarrowia lipolytica as alternative models for analysing budding patterns and germ tube formation in dimorphic fungi.
    Herrero AB; López MC; Fernández-Lago L; Domínguez A
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2727-37. PubMed ID: 10537194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural alterations of Candida albicans induced by a new imidazole antimycotic omoconazole nitrate.
    Nishiyama Y; Itoyama T; Yamaguchi H
    Microbiol Immunol; 1997; 41(5):395-402. PubMed ID: 9194038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the cultivation conditions of Candida species yeast-like fungi on their sensitivity to levorin].
    Vasil'eva NG; Fradkova TA; Golubkova LS
    Antibiotiki; 1977 May; 22(5):433-7. PubMed ID: 327914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
    Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological changes of Candida albicans induced by saperconazole.
    Montès B; Mallié M; Jouvert S; Bastide JM
    Mycoses; 1991; 34(7-8):287-92. PubMed ID: 1803228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in surface morphology of Candida albicans produced by rilopirox: a scanning electron microscopy study.
    Braga PC; Maci S; Dal Sasso M; Piatti G; Bohn M
    J Chemother; 1995 Dec; 7(6):519-24. PubMed ID: 8667036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cisplatin and two novel palladium complexes on Candida albicans.
    Moussa NM; Ghannoum MA; Whittaker PA; el-Ezaby MS; Quraman S
    Microbios; 1990; 62(252-253):165-78. PubMed ID: 2195302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of taxonomically diverse fungi to pentamidine isethionate.
    Ludewig G; Staben C
    J Eukaryot Microbiol; 1994; 41(5):103S. PubMed ID: 7804197
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy.
    Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC
    J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.